Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosineB Masquelier, I Pellegrin, A Ruffault, et al.Clinical Immunology (Orlando, Fla.)|May 19, 2001
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapyM Savès, P Morlat, G Chêne, et al.The Journal of Infectious Diseases|June 2, 1998
JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patientsM E Lafon, H Dutronc, V Dubois, et al.AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loadsI Pellegrin, E Legrand, D Neau, et al.Journal of Clinical Microbiology|October 17, 1998
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapyM Segondy, J Izopet, I Pellegrin, et al.La Revue De Medecine Interne|January 1, 1995
[Disseminated Mycobacterium avium complex infections in AIDS. Apropos of 100 cases. Groupe d'Epidémiologie clinique du SIDA en Aquitaine]C Lasseur, J Maugein, J L Pellegrin, et al.La Revue De Medecine Interne|January 1, 1993
[Interferon and blood tumor necrosis factor in 95 patients with HIV infection]J Constans, J L Pellegrin, I Pellegrin, et al.Clinical Biochemistry|August 1, 1995
Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological statusJ Constans, E Peuchant, J L Pellegrin, et al.The Journal of Infectious Diseases|July 4, 1998
Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapyM Dalod, M Harzic, I Pellegrin, et al.Pageof 4